Vaxart Inc. Stock
Vaxart Inc. Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Vaxart Inc. stock is not clear.
Our community identified positive and negative aspects for Vaxart Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Vaxart Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Vaxart Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vaxart Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vaxart Inc. | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -1.560% | -4.950% | -2.538% | 90.099% | 15.663% | -4.950% | -60.000% |
| Northwest Biotherapeutics Inc. | 0.000% | -8.889% | -0.606% | -41.844% | -20.388% | -63.393% | -85.091% |
| Celldex Therapeutics | -1.130% | -0.071% | 5.597% | 64.535% | 28.636% | -8.710% | 28.871% |
Comments
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AVIR provided by MarketBeat
News
3 Stocks Under $5 With Strong Analyst Upside Potential
At a time when many investors are rotating out of speculative penny stocks, others continue to embrace the risk-reward dynamic. Stocks that trade for under $5 carry a certain amount of risk. Many
The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway)
Penny stocks attract speculative investors looking for high-risk/high-reward opportunities. That means looking for companies with disruptive technologies, that are part of an emerging trend, or